DK1912976T3 - Indol-3-YL-carbonyl-piperidin-benzoimidazolderivater som V1A-receptorantagonister - Google Patents

Indol-3-YL-carbonyl-piperidin-benzoimidazolderivater som V1A-receptorantagonister

Info

Publication number
DK1912976T3
DK1912976T3 DK06777681T DK06777681T DK1912976T3 DK 1912976 T3 DK1912976 T3 DK 1912976T3 DK 06777681 T DK06777681 T DK 06777681T DK 06777681 T DK06777681 T DK 06777681T DK 1912976 T3 DK1912976 T3 DK 1912976T3
Authority
DK
Denmark
Prior art keywords
indol
piperidine
carbonyl
receptor antagonists
benzoimidazole derivatives
Prior art date
Application number
DK06777681T
Other languages
English (en)
Inventor
Hasane Ratni
Patrick Schnider
Caterina Bissantz
Christophe Grundschober
Mark Rogers-Evans
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1912976T3 publication Critical patent/DK1912976T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK06777681T 2005-07-21 2006-07-11 Indol-3-YL-carbonyl-piperidin-benzoimidazolderivater som V1A-receptorantagonister DK1912976T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05106695 2005-07-21
EP05110506 2005-11-09
PCT/EP2006/064075 WO2007009906A1 (en) 2005-07-21 2006-07-11 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists

Publications (1)

Publication Number Publication Date
DK1912976T3 true DK1912976T3 (da) 2009-01-26

Family

ID=37192471

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06777681T DK1912976T3 (da) 2005-07-21 2006-07-11 Indol-3-YL-carbonyl-piperidin-benzoimidazolderivater som V1A-receptorantagonister

Country Status (21)

Country Link
US (2) US7803815B2 (da)
EP (1) EP1912976B1 (da)
JP (1) JP4839374B2 (da)
KR (1) KR100984893B1 (da)
CN (1) CN101268067A (da)
AR (1) AR056188A1 (da)
AT (1) ATE414078T1 (da)
AU (1) AU2006271804B2 (da)
BR (1) BRPI0613656A2 (da)
CA (1) CA2616063A1 (da)
DE (1) DE602006003666D1 (da)
DK (1) DK1912976T3 (da)
ES (1) ES2314941T3 (da)
IL (1) IL188722A (da)
MX (1) MX2008000886A (da)
NO (1) NO20080291L (da)
PL (1) PL1912976T3 (da)
PT (1) PT1912976E (da)
RU (1) RU2415139C2 (da)
TW (1) TWI324601B (da)
WO (1) WO2007009906A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008001292A (es) * 2005-07-29 2008-03-25 Hoffmann La Roche Nuevos derivados de indol-3-il-carbonil-piperidina y piperazina.
WO2008068184A1 (en) 2006-12-08 2008-06-12 F. Hoffmann-La Roche Ag Indoles which act as via receptor antagonists
PE20081401A1 (es) * 2006-12-28 2008-10-24 Hoffmann La Roche Derivados de indol como antagonistas de receptores vasopresina
KR101577943B1 (ko) * 2008-01-31 2015-12-16 사노피 사이클릭 아자인돌-3-카복스아미드, 이들의 제조방법 및 약제로서의 이들의 용도
HUP1000598A2 (en) 2010-11-05 2012-09-28 Richter Gedeon Nyrt Indole derivatives
EP2548864B1 (en) 2011-07-22 2014-02-19 Université Joseph Fourier Novel bis-indolic derivatives, a process for preparing the same and their uses as a drug
JP7368357B2 (ja) * 2017-09-05 2023-10-24 ブラックソーン セラピューティクス インコーポレイテッド バソプレシン受容体アンタゴニストならびにそれに関連する生成物および方法
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素V1a受體拮抗劑之三環化合物
JP2022530474A (ja) * 2019-04-26 2022-06-29 ジェネロス バイオファーマ リミテッド 複素環含有化合物、その使用及びそれを含む組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686624A (en) * 1992-01-30 1997-11-11 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
DE19725664A1 (de) * 1997-06-18 1998-12-24 Merck Patent Gmbh 3-Benzylpiperidine
AUPP150098A0 (en) * 1998-01-27 1998-02-19 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives
DE60132611T2 (de) * 2000-10-27 2009-02-19 Ortho-Mcneil Pharmaceutical, Inc. Substituierte benzimidazol-2-one als vasopressin receptor antagonisten und neuropeptide y modulatoren
TWI317634B (en) * 2001-12-13 2009-12-01 Nat Health Research Institutes Aroyl indoles compounds

Also Published As

Publication number Publication date
EP1912976B1 (en) 2008-11-12
AU2006271804B2 (en) 2011-03-31
RU2415139C2 (ru) 2011-03-27
US20070021463A1 (en) 2007-01-25
TW200740792A (en) 2007-11-01
AR056188A1 (es) 2007-09-26
RU2008100780A (ru) 2009-08-27
IL188722A (en) 2012-12-31
JP4839374B2 (ja) 2011-12-21
CN101268067A (zh) 2008-09-17
US7803815B2 (en) 2010-09-28
BRPI0613656A2 (pt) 2011-01-25
KR100984893B1 (ko) 2010-10-01
ES2314941T3 (es) 2009-03-16
AU2006271804A1 (en) 2007-01-25
TWI324601B (en) 2010-05-11
KR20080027950A (ko) 2008-03-28
EP1912976A1 (en) 2008-04-23
DE602006003666D1 (de) 2008-12-24
ATE414078T1 (de) 2008-11-15
JP2009501757A (ja) 2009-01-22
PT1912976E (pt) 2009-01-07
NO20080291L (no) 2008-03-06
WO2007009906A1 (en) 2007-01-25
MX2008000886A (es) 2008-03-18
IL188722A0 (en) 2008-08-07
CA2616063A1 (en) 2007-01-25
PL1912976T3 (pl) 2009-04-30
US20100256140A1 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
DK1863818T3 (da) Acetylenyl-pyrazolo-pyrimidinderivater som mglur2-antagonister
IL188478A0 (en) Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists
DK2094709T3 (da) Thiazol-pyrazolopyrimidiner som CRF1-receptorantagonister
LTPA2017005I1 (lt) Nauji junginiai, kaip opioido receptoriaus moduliatoriai
DK2089382T3 (da) Substituerede diazepan-forbindelser som orexin-receptor-antagonister
ATE505467T1 (de) 2-aza-bicycloä3.1.0ühexanderivate als orexin- rezeptorantagonisten
DK2004654T3 (da) Pyrazolopyrimidin derivater til anvendelse som kinase antagonister
DK1863474T3 (da) Hidtil ukendte thiophenderivater som sphingosin-1-phosphat-1-receptoragonister
DK2029549T3 (da) Phenyl-pyrazol-derivater som ikke-steroide glucocoricoid-receptorligander
DK1663996T3 (da) (Thio)carbamoylcyclohexanderivater som D3/D2-receptorantagonister
DK2089367T3 (da) Pyrazolinforbindelser som mineralocorticoidreceptor-antagonister
DK2170831T3 (da) Benzazepin-derivater egnede som vasopressin-antagonister
EP1981902A4 (en) ANTAGONISTS OF NOGO RECEPTORS
DK1761519T3 (da) Indolderivater som histaminreceptorantagonister
DK1856110T3 (da) Oxyindol derivater som 5HT4-receptor agonister
DK2069310T3 (da) Sulfonylpyrazolin-1-carboxamidin-derivater som 5-HT6-antagonister
EP2079466A4 (en) SUBSTITUTED INDOLE COMPOUNDS
IL192308A0 (en) Oxazoloisoquinoline derivatives as thrombin receptor antagonists
DK1841758T3 (da) Substituerede triazol-derivater som oxytocin-antagonister
DK1711465T3 (da) Hydroisoindolin-tachykinikreceptorantagonister
ATE549350T1 (de) Neuropeptid-2-rezeptor-agonisten
DK1833791T3 (da) 2,3,4,9-tetrahydor-1H-carbazolderivater som CRTH2 receptorantagonister
DK1943242T3 (da) Piperidin-4-yl-pyridazin-3-ylamin-derivater som hurtigt opløsende antagonister af dopamin-2-receptorer
DK1973886T3 (da) Prokineticin-1-receptor-antagonister
DK2205569T3 (da) Alkylthiopyrimidiner som crth2-antagonister